Pixelgate Recon scout the market · before you launch
Home Master ↗
← Back to session
research.advertiser

The Wellness Room

Every ad this advertiser ran in this session. gevilo.com ↗

2 Ads run
22 Max days running
1 Keywords matched
1 Session seen in
surfaced under keywords
get placed fast
research.ads

Individual ads

Sorted by days-running. Each card shows the actual ad creative (thumbnail, body copy, CTA). Click "Read more" to expand body copy.

image #2
22d running LEARN_MORE get placed fast
TYPE 2 DIABETICS DON'T DIE FROM F*CKING HEART ATTACKS. They don't die from strokes. They don't die from strokes. They don't even die from their blood sugar numbers. I know because I've been a cardiologist for 26 years. And I have watched this thing kill more of my patients than heart attacks and strokes combined. My name is Dr Claire Barton. Consultant interventional cardiologist. Twenty-six years of practice in Birmingham. I have fitted more stents than I can count. I have delivered more post-cardiac-event protocols than I can count. I have sat across from more Type 2 diabetic patients af
Read more (full body)
TYPE 2 DIABETICS DON'T DIE FROM F*CKING HEART ATTACKS. They don't die from strokes. They don't die from strokes. They don't even die from their blood sugar numbers. I know because I've been a cardiologist for 26 years. And I have watched this thing kill more of my patients than heart attacks and strokes combined. My name is Dr Claire Barton. Consultant interventional cardiologist. Twenty-six years of practice in Birmingham. I have fitted more stents than I can count. I have delivered more post-cardiac-event protocols than I can count. I have sat across from more Type 2 diabetic patients after their first event. You are managed. I said it to hundreds of patients. I meant it. I believed it. I believed it until I was lying in a hospital bed at 3am at 61 years old with two stents in my own left anterior descending artery and a registrar I had trained twelve years earlier checking my rhythm on a monitor six feet from my face. I was the patient. Everything I had prescribed to hundreds of other people had not saved me. That is the part I need you to understand first. Because the thing that killed my father and almost killed me is not on any warning label. It is not in any public health campaign. It is not in any advert you have ever seen. And it is absolutely not something your GP is going to sit you down and explain. Here is what it is. Everyone with Type 2 diabetes is told the same thing. Watch your HbA1c. Watch your fasting glucose. Keep the numbers down. Take the Metformin. Take the blood pressure tablet. Take the statin. Cut the bread. Walk after dinner. And most people do. Most of my patients did exactly that. My father did exactly that for eleven years before he died at 66 in A&E at a hospital where two of his former colleagues worked. Eleven years of Metformin. Blood pressure controlled. HbA1c sitting at 51 and holding. He was managed. His GP said so. His cardiologist said so. Everyone who looked at his notes said so. And then one Tuesday morning he did not wake up. I became a cardiologist because of that Tuesday morning. I spent twenty-six years believing that if I could catch the numbers early enough and tighten the protocol, I could prevent for my patients what had happened to my father. I could not. Because the thing that killed my father was never his HbA1c. It was never his blood pressure reading. It was never his cholesterol number. Those were all downstream. Every one of those numbers was the echo of the real problem, not the problem itself. The real problem is this. Your body has a pathway that controls how fast food becomes sugar in your blood. When it works, food breaks down slowly and sugar trickles in. Your insulin handles it calmly. But years of elevated blood sugar, processed food and stress wear that pathway down. Gradually. Until one day it cannot control the speed any more. Food does not trickle into your blood. It floods in. And the flood does not sit still. It moves. Every meal. Three times a day. As it moves, it grinds against the walls of every blood vessel in your body. The large arteries. The small vessels. The capillaries feeding your feet, your kidneys, your eyes, your liver, and your heart. Grinding. Silently. For years. Your HbA1c gives you an average. A ninety-day average. It does not tell you about the flood after every meal. It does not show you the real-time damage happening to your vessel walls while the average looks acceptable. It does not show you what is happening to the capillaries in your kidneys, or the vessels feeding the nerves in your feet, or the arterial lining feeding your heart. It shows you a number that your doctor can call managed. Metformin tells your liver to release less stored sugar overnight. It helps bring the number down. It does not repair the pathway. It does not stop the flood. It does not repair the vessel walls the flood has been grinding against for years. Ramipril manages your blood pressure reading. It does not repair the arterial lining. The statin manages your cholesterol. It does not stop the mechanism that is driving the cholesterol problem in the first place. Three medications. Three downstream numbers. Not one of them touches the mechanism upstream. I know this now. I understood it clinically before I ever understood it in my own body. I was diagnosed with Type 2 diabetes at 55. Fasting glucose 8.0. HbA1c 54. I did what any cardiologist would prescribe for herself. Metformin at diagnosis. Ramipril the following year. A statin the year after that. I walked every morning before my first case. I cut the things I told my patients to cut. I dropped a stone and kept it off. By year five, my HbA1c was 45. My blood pressure was reading managed. My cholesterol was controlled. In year six I arranged a CT calcium score on myself. Privately. It is not something the NHS offers a diabetic whose numbers read managed — which is exactly the point. Nobody was ever going to order this scan for me. The managed numbers said there was no need. The score came back at 819. I have called patients with scores less than half that size and told them to clear their afternoon and come in immediately. I told myself I would book a CT angiogram the following week. I did not book it. Two weeks became four. Four became six. Six became the morning I woke my husband at 2:47am reaching across the bed for his hand. The pressure started in my chest and moved into my jaw and I knew before I finished the thought what it was. We drove forty minutes to a different hospital. I was not going to be wheeled past registrars I had trained on a trolley wearing a patient gown. The registrar on call that night had rotated through my unit eight years earlier. He recognised me before I recognised him. He got me into the cath lab in eleven minutes. Two stents. Left anterior descending artery. The same procedure I had performed more than four hundred times on other people. I was in coronary care for four days. On the second day I asked my consultant, a colleague I had trained, to run the full metabolic workup. Not just the cardiac panels. Everything. The kidney report came first. My eGFR had dropped from 88 four years earlier to 74. A quiet decline nobody had flagged because my HbA1c had read managed and the system does not trigger a renal referral on a creatinine that looks acceptable. The eye specialist found early background retinopathy in my right eye. I had been struggling to read operative reports for eight months and had blamed my reading glasses. The foot examination flagged early peripheral neuropathy in both feet. Right side worse than left. I had attributed the occasional numbness to long days standing in theatre. Same disease. Same flood. Grinding through five separate organ systems while every number on my chart read acceptable. I lay in that hospital bed and understood something I had not allowed myself to understand in twenty-six years of practice. I had been prescribing the same three-medication protocol to hundreds of patients with Type 2 diabetes. Every prescription was guideline-compliant. Every one addressed a downstream measurement. Not one of them had repaired the pathway. Not one of them had stopped the flood. Not one of them had repaired the vessel walls it had been grinding against. I went home on day eight. I sat at my desk at 11pm with my husband asleep down the hall and I opened the journals. Not the guideline papers. Not the drug outcomes studies. The mechanism papers. How the pathway breaks. What the flood does to the vessel lining, year after year. All of it sitting in journals I had subscribed to for twenty-six years. I had read every issue for the intervention studies and the stent trials. I had never read them for the mechanism papers, because my training had taught me the mechanism was something to manage, not something to address at the source. My training had been wrong. I read until 3am. I closed the laptop and sat at my kitchen table in the dark. Three weeks later a patient came in for a follow-up that stopped me cold. Her name was Yasmin. Type 2 diabetic. Fourteen years post-diagnosis. She had transferred to my clinic after a stent two years earlier. At intake her HbA1c had been 65. She was on Metformin, ramipril and a statin. I pulled her notes before she walked in, expecting to add a medication. Her HbA1c was 36. Her blood pressure was 112 over 72. She had come off ramipril nine months earlier after her GP agreed the readings no longer supported the prescription. Her cholesterol was the best it had been in a decade. Her triglycerides had dropped by more than half from her intake panel. I looked at her across the exam table and asked her what she had done. She said, Dr Barton, my family in Sicily has taken this every morning for as long as anyone can remember. I did not bring it up before because I thought you might not take it seriously. She wrote a name on my notepad. Gevilo. I will be honest. My first reaction was to almost laugh. Milk thistle. The herb I had watched hundreds of my patients take over the years, with nothing to show for it. If I had read her bloods without knowing her, I would have assumed a lab error. But I had ordered the repeat myself. I researched it that evening. Here is the mechanism. The one that had been sitting in the journals for years while the guidelines were built around managing downstream numbers. Milk thistle — not at the concentration on every shelf, but standardised to 80 percent silymarin, the level the research actually used — has one active fraction the clinical literature comes back to every time. Documented in studies going back decades, and at the right concentration, it held up. These two ingredients do two things no drug in the standard protocol does. The first: milk thistle at 80 percent silymarin supports the liver's own cell regeneration cycle. The liver controls how much stored glucose is released into your blood. When those cells recover, the release slows back to its natural pace. Food stops flooding your blood vessels. Not managed down. Repaired. The second: wormwood and clove clear the hepatic congestion — the buildup the liver has been too overwhelmed to move on its own — so the vessel lining the flood has been grinding against for years can finally begin to recover. The vessels in your feet. Your kidneys. Your eyes. Your liver. Your coronary arteries. Two ingredients. Two jobs. One stops the flood. The other helps repair what the flood damaged while the pathway was broken. The research had been there. I had access to those journals for over two decades and never followed the thread, because my training pointed me toward intervention outcomes, not upstream mechanism. The guidelines addressed downstream measurements because that is what the drug approval process runs on. Measurable downstream biomarkers. Tractable targets. Prescribable compounds. Milk thistle is not a drug. You cannot patent an ancient herb. There is no trial funding for a plant that cannot be owned. So the mechanism papers sat in the journals and the guidelines stayed built around Metformin and ramipril and statins and the monthly prescriptions they generate. I ordered Gevilo from my office. They arrived on a Thursday. I took the first capsule Friday morning with breakfast. Week one. The afternoon fatigue I had been writing off to cardiac recovery began to lift. By day six I was reading case notes at 4pm without needing to lie down. Week two. The tingling in my right foot that the examination had documented began to quiet. I slept through the night without the burning that had been waking me. Week three. My home blood pressure cuff was reading 121 over 75. I had not changed a single medication. Week four. I booked a private blood panel. I ran it twice because I did not believe it. Both runs matched. Week six. Fasting glucose 5.2. Down from 7.8 at discharge. Week eight. HbA1c 40. Week twelve. Full metabolic panel. HbA1c 36. Fasting glucose 4.8. Triglycerides down by half. Creatinine back to normal. eGFR climbed from 74 to 85. Liver enzymes normalised. I brought the twelve-week panel to my practice partner. I placed my discharge bloods next to it on his desk and said nothing. He read them. He looked up. He said, Claire. What did you do. I told him. He listened for thirty minutes without interrupting. Then he said, I want to run this with my own patients. He has been using it with eleven post-cardiac patients for the last four months. Seven of them have moved out of diabetic range. Two have discontinued ramipril at their GPs' recommendation. My own statin was discontinued at month four. My last HbA1c three weeks ago was 34. Now here is what I need you to understand about how to get this right. Because this is exactly where most people go wrong and end up concluding it does not work. The silymarin in milk thistle does not become therapeutically meaningful at every concentration. It only works at the level where it can penetrate liver cells and support their regeneration. At 50 to 65 percent — what is on every shelf — it never gets there. The difference looks small on a label. In your liver it is the difference between reaching the cells that need repair and not reaching them. You would be taking the right herb at the wrong strength. And nearly every milk thistle product on the shelf is sold without wormwood and clove. Without the second ingredient doing the second job, the first ingredient has nowhere to go. The congestion stays. The vessel lining stays under attack. That is why anyone who has tried a supermarket milk thistle product and seen nothing is telling the absolute truth. The herb was right. The concentration and combination could never work. Gevilo uses milk thistle standardised to 80 percent silymarin. Not the 50 to 65 percent on every shelf. The concentration where the compound actually reaches the liver cells that need it. Paired with wormwood extract and clove, so both jobs are covered in one capsule. No fillers. No artificial additives. One capsule with water every morning. Now here is what I need you to hear about where to get it. Gevilo is not sold on Amazon. It is not in Holland & Barrett. It is not through any third-party marketplace. That is deliberate. Third-party platforms allow sellers to list products under the same name while substituting ingredients. I have seen patients bring in milk thistle supplements ordered from Amazon. None of them were standardised to 80 percent silymarin. None of them were paired with wormwood and clove. Not one. The only place you can verify you are receiving the right concentration with the right combination is directly from the official Gevilo website. That verification is the entire point. And here is why the time window matters. Remember what I told you about the HbA1c. It is a ninety-day average. The same average that hid the flood for years is the only thing that can prove the flood has stopped. The floods you stop this week will not show in the number for weeks. One full test cycle. Ninety days. That is why the correct supply is three months. One capsule a day, no gaps, so the mechanism has the full runway to work. That is also why Gevilo backs the protocol with a 90-day money-back guarantee. Not sixty days. Not thirty. Ninety days, which is the full length of the protocol. If your numbers do not move in that window, you pay nothing and you keep what is left. They offer that guarantee because the mechanism requires the full course to show in your bloods, and they know it. One more thing. Supply is not unlimited. Because the three-month protocol is the only protocol that works, people order three bottles at a time. When stock runs low it runs low across every option at once, and milk thistle standardised to 80 percent silymarin is not something that can be restocked quickly. If you can see this and the product is available, do not assume that will still be the case in a week. I am still practising. My hospital privileges are intact. I have fitted four stents in the months since my own cardiac event. I will never fit one again without understanding what I now understand about the mechanism that put my patients on that table. And the mechanism that put me on it. My father was managed for eleven years. His numbers read fine. He died at 66. I was managed for six years. My numbers read fine. I had my event at 61 with two stents placed by someone I had trained. The difference between my father's outcome and my current bloods is not a new drug. It is not a new procedure. It is one combination from an ancient herb that has been in the mechanism literature for years while the guidelines were built around managing the downstream measurements that combination eventually makes unnecessary. If someone you love has Type 2 diabetes and their doctor is calling them managed, please share this with them. Managed is not improving. I know what improving looks like now. I have seen it in my own bloods and in eleven of my colleague's patients. It does not look like managed. It looks like the mechanism finally being addressed instead of downstream numbers being tracked while the mechanism continues grinding. Get the three-month supply. Follow the protocol. Give the mechanism the runway it requires. Your bloods will tell you everything you need to know by day ninety. Official Gevilo website only. Not Amazon. Not Holland & Barrett. Not any third-party seller. 👉 https://gevilo.com/pages/milk-thistle The system that trained me did not give me this when I needed it. It is reaching you now.
image #3
22d running LEARN_MORE get placed fast
TYPE 2 DIABETICS DON'T DIE FROM F*CKING HEART ATTACKS. They don't die from strokes. They don't die from strokes. They don't even die from their blood sugar numbers. I know because I've been a cardiologist for 26 years. And I have watched this thing kill more of my patients than heart attacks and strokes combined. My name is Dr Claire Barton. Consultant interventional cardiologist. Twenty-six years of practice in Birmingham. I have fitted more stents than I can count. I have delivered more post-cardiac-event protocols than I can count. I have sat across from more Type 2 diabetic patients af
Read more (full body)
TYPE 2 DIABETICS DON'T DIE FROM F*CKING HEART ATTACKS. They don't die from strokes. They don't die from strokes. They don't even die from their blood sugar numbers. I know because I've been a cardiologist for 26 years. And I have watched this thing kill more of my patients than heart attacks and strokes combined. My name is Dr Claire Barton. Consultant interventional cardiologist. Twenty-six years of practice in Birmingham. I have fitted more stents than I can count. I have delivered more post-cardiac-event protocols than I can count. I have sat across from more Type 2 diabetic patients after their first event. You are managed. I said it to hundreds of patients. I meant it. I believed it. I believed it until I was lying in a hospital bed at 3am at 61 years old with two stents in my own left anterior descending artery and a registrar I had trained twelve years earlier checking my rhythm on a monitor six feet from my face. I was the patient. Everything I had prescribed to hundreds of other people had not saved me. That is the part I need you to understand first. Because the thing that killed my father and almost killed me is not on any warning label. It is not in any public health campaign. It is not in any advert you have ever seen. And it is absolutely not something your GP is going to sit you down and explain. Here is what it is. Everyone with Type 2 diabetes is told the same thing. Watch your HbA1c. Watch your fasting glucose. Keep the numbers down. Take the Metformin. Take the blood pressure tablet. Take the statin. Cut the bread. Walk after dinner. And most people do. Most of my patients did exactly that. My father did exactly that for eleven years before he died at 66 in A&E at a hospital where two of his former colleagues worked. Eleven years of Metformin. Blood pressure controlled. HbA1c sitting at 51 and holding. He was managed. His GP said so. His cardiologist said so. Everyone who looked at his notes said so. And then one Tuesday morning he did not wake up. I became a cardiologist because of that Tuesday morning. I spent twenty-six years believing that if I could catch the numbers early enough and tighten the protocol, I could prevent for my patients what had happened to my father. I could not. Because the thing that killed my father was never his HbA1c. It was never his blood pressure reading. It was never his cholesterol number. Those were all downstream. Every one of those numbers was the echo of the real problem, not the problem itself. The real problem is this. Your body has a pathway that controls how fast food becomes sugar in your blood. When it works, food breaks down slowly and sugar trickles in. Your insulin handles it calmly. But years of elevated blood sugar, processed food and stress wear that pathway down. Gradually. Until one day it cannot control the speed any more. Food does not trickle into your blood. It floods in. And the flood does not sit still. It moves. Every meal. Three times a day. As it moves, it grinds against the walls of every blood vessel in your body. The large arteries. The small vessels. The capillaries feeding your feet, your kidneys, your eyes, your liver, and your heart. Grinding. Silently. For years. Your HbA1c gives you an average. A ninety-day average. It does not tell you about the flood after every meal. It does not show you the real-time damage happening to your vessel walls while the average looks acceptable. It does not show you what is happening to the capillaries in your kidneys, or the vessels feeding the nerves in your feet, or the arterial lining feeding your heart. It shows you a number that your doctor can call managed. Metformin tells your liver to release less stored sugar overnight. It helps bring the number down. It does not repair the pathway. It does not stop the flood. It does not repair the vessel walls the flood has been grinding against for years. Ramipril manages your blood pressure reading. It does not repair the arterial lining. The statin manages your cholesterol. It does not stop the mechanism that is driving the cholesterol problem in the first place. Three medications. Three downstream numbers. Not one of them touches the mechanism upstream. I know this now. I understood it clinically before I ever understood it in my own body. I was diagnosed with Type 2 diabetes at 55. Fasting glucose 8.0. HbA1c 54. I did what any cardiologist would prescribe for herself. Metformin at diagnosis. Ramipril the following year. A statin the year after that. I walked every morning before my first case. I cut the things I told my patients to cut. I dropped a stone and kept it off. By year five, my HbA1c was 45. My blood pressure was reading managed. My cholesterol was controlled. In year six I arranged a CT calcium score on myself. Privately. It is not something the NHS offers a diabetic whose numbers read managed — which is exactly the point. Nobody was ever going to order this scan for me. The managed numbers said there was no need. The score came back at 819. I have called patients with scores less than half that size and told them to clear their afternoon and come in immediately. I told myself I would book a CT angiogram the following week. I did not book it. Two weeks became four. Four became six. Six became the morning I woke my husband at 2:47am reaching across the bed for his hand. The pressure started in my chest and moved into my jaw and I knew before I finished the thought what it was. We drove forty minutes to a different hospital. I was not going to be wheeled past registrars I had trained on a trolley wearing a patient gown. The registrar on call that night had rotated through my unit eight years earlier. He recognised me before I recognised him. He got me into the cath lab in eleven minutes. Two stents. Left anterior descending artery. The same procedure I had performed more than four hundred times on other people. I was in coronary care for four days. On the second day I asked my consultant, a colleague I had trained, to run the full metabolic workup. Not just the cardiac panels. Everything. The kidney report came first. My eGFR had dropped from 88 four years earlier to 74. A quiet decline nobody had flagged because my HbA1c had read managed and the system does not trigger a renal referral on a creatinine that looks acceptable. The eye specialist found early background retinopathy in my right eye. I had been struggling to read operative reports for eight months and had blamed my reading glasses. The foot examination flagged early peripheral neuropathy in both feet. Right side worse than left. I had attributed the occasional numbness to long days standing in theatre. Same disease. Same flood. Grinding through five separate organ systems while every number on my chart read acceptable. I lay in that hospital bed and understood something I had not allowed myself to understand in twenty-six years of practice. I had been prescribing the same three-medication protocol to hundreds of patients with Type 2 diabetes. Every prescription was guideline-compliant. Every one addressed a downstream measurement. Not one of them had repaired the pathway. Not one of them had stopped the flood. Not one of them had repaired the vessel walls it had been grinding against. I went home on day eight. I sat at my desk at 11pm with my husband asleep down the hall and I opened the journals. Not the guideline papers. Not the drug outcomes studies. The mechanism papers. How the pathway breaks. What the flood does to the vessel lining, year after year. All of it sitting in journals I had subscribed to for twenty-six years. I had read every issue for the intervention studies and the stent trials. I had never read them for the mechanism papers, because my training had taught me the mechanism was something to manage, not something to address at the source. My training had been wrong. I read until 3am. I closed the laptop and sat at my kitchen table in the dark. Three weeks later a patient came in for a follow-up that stopped me cold. Her name was Yasmin. Type 2 diabetic. Fourteen years post-diagnosis. She had transferred to my clinic after a stent two years earlier. At intake her HbA1c had been 65. She was on Metformin, ramipril and a statin. I pulled her notes before she walked in, expecting to add a medication. Her HbA1c was 36. Her blood pressure was 112 over 72. She had come off ramipril nine months earlier after her GP agreed the readings no longer supported the prescription. Her cholesterol was the best it had been in a decade. Her triglycerides had dropped by more than half from her intake panel. I looked at her across the exam table and asked her what she had done. She said, Dr Barton, my family in Sicily has taken this every morning for as long as anyone can remember. I did not bring it up before because I thought you might not take it seriously. She wrote a name on my notepad. Gevilo. I will be honest. My first reaction was to almost laugh. Milk thistle. The herb I had watched hundreds of my patients take over the years, with nothing to show for it. If I had read her bloods without knowing her, I would have assumed a lab error. But I had ordered the repeat myself. I researched it that evening. Here is the mechanism. The one that had been sitting in the journals for years while the guidelines were built around managing downstream numbers. Milk thistle — not at the concentration on every shelf, but standardised to 80 percent silymarin, the level the research actually used — has one active fraction the clinical literature comes back to every time. Documented in studies going back decades, and at the right concentration, it held up. These two ingredients do two things no drug in the standard protocol does. The first: milk thistle at 80 percent silymarin supports the liver's own cell regeneration cycle. The liver controls how much stored glucose is released into your blood. When those cells recover, the release slows back to its natural pace. Food stops flooding your blood vessels. Not managed down. Repaired. The second: wormwood and clove clear the hepatic congestion — the buildup the liver has been too overwhelmed to move on its own — so the vessel lining the flood has been grinding against for years can finally begin to recover. The vessels in your feet. Your kidneys. Your eyes. Your liver. Your coronary arteries. Two ingredients. Two jobs. One stops the flood. The other helps repair what the flood damaged while the pathway was broken. The research had been there. I had access to those journals for over two decades and never followed the thread, because my training pointed me toward intervention outcomes, not upstream mechanism. The guidelines addressed downstream measurements because that is what the drug approval process runs on. Measurable downstream biomarkers. Tractable targets. Prescribable compounds. Milk thistle is not a drug. You cannot patent an ancient herb. There is no trial funding for a plant that cannot be owned. So the mechanism papers sat in the journals and the guidelines stayed built around Metformin and ramipril and statins and the monthly prescriptions they generate. I ordered Gevilo from my office. They arrived on a Thursday. I took the first capsule Friday morning with breakfast. Week one. The afternoon fatigue I had been writing off to cardiac recovery began to lift. By day six I was reading case notes at 4pm without needing to lie down. Week two. The tingling in my right foot that the examination had documented began to quiet. I slept through the night without the burning that had been waking me. Week three. My home blood pressure cuff was reading 121 over 75. I had not changed a single medication. Week four. I booked a private blood panel. I ran it twice because I did not believe it. Both runs matched. Week six. Fasting glucose 5.2. Down from 7.8 at discharge. Week eight. HbA1c 40. Week twelve. Full metabolic panel. HbA1c 36. Fasting glucose 4.8. Triglycerides down by half. Creatinine back to normal. eGFR climbed from 74 to 85. Liver enzymes normalised. I brought the twelve-week panel to my practice partner. I placed my discharge bloods next to it on his desk and said nothing. He read them. He looked up. He said, Claire. What did you do. I told him. He listened for thirty minutes without interrupting. Then he said, I want to run this with my own patients. He has been using it with eleven post-cardiac patients for the last four months. Seven of them have moved out of diabetic range. Two have discontinued ramipril at their GPs' recommendation. My own statin was discontinued at month four. My last HbA1c three weeks ago was 34. Now here is what I need you to understand about how to get this right. Because this is exactly where most people go wrong and end up concluding it does not work. The silymarin in milk thistle does not become therapeutically meaningful at every concentration. It only works at the level where it can penetrate liver cells and support their regeneration. At 50 to 65 percent — what is on every shelf — it never gets there. The difference looks small on a label. In your liver it is the difference between reaching the cells that need repair and not reaching them. You would be taking the right herb at the wrong strength. And nearly every milk thistle product on the shelf is sold without wormwood and clove. Without the second ingredient doing the second job, the first ingredient has nowhere to go. The congestion stays. The vessel lining stays under attack. That is why anyone who has tried a supermarket milk thistle product and seen nothing is telling the absolute truth. The herb was right. The concentration and combination could never work. Gevilo uses milk thistle standardised to 80 percent silymarin. Not the 50 to 65 percent on every shelf. The concentration where the compound actually reaches the liver cells that need it. Paired with wormwood extract and clove, so both jobs are covered in one capsule. No fillers. No artificial additives. One capsule with water every morning. Now here is what I need you to hear about where to get it. Gevilo is not sold on Amazon. It is not in Holland & Barrett. It is not through any third-party marketplace. That is deliberate. Third-party platforms allow sellers to list products under the same name while substituting ingredients. I have seen patients bring in milk thistle supplements ordered from Amazon. None of them were standardised to 80 percent silymarin. None of them were paired with wormwood and clove. Not one. The only place you can verify you are receiving the right concentration with the right combination is directly from the official Gevilo website. That verification is the entire point. And here is why the time window matters. Remember what I told you about the HbA1c. It is a ninety-day average. The same average that hid the flood for years is the only thing that can prove the flood has stopped. The floods you stop this week will not show in the number for weeks. One full test cycle. Ninety days. That is why the correct supply is three months. One capsule a day, no gaps, so the mechanism has the full runway to work. That is also why Gevilo backs the protocol with a 90-day money-back guarantee. Not sixty days. Not thirty. Ninety days, which is the full length of the protocol. If your numbers do not move in that window, you pay nothing and you keep what is left. They offer that guarantee because the mechanism requires the full course to show in your bloods, and they know it. One more thing. Supply is not unlimited. Because the three-month protocol is the only protocol that works, people order three bottles at a time. When stock runs low it runs low across every option at once, and milk thistle standardised to 80 percent silymarin is not something that can be restocked quickly. If you can see this and the product is available, do not assume that will still be the case in a week. I am still practising. My hospital privileges are intact. I have fitted four stents in the months since my own cardiac event. I will never fit one again without understanding what I now understand about the mechanism that put my patients on that table. And the mechanism that put me on it. My father was managed for eleven years. His numbers read fine. He died at 66. I was managed for six years. My numbers read fine. I had my event at 61 with two stents placed by someone I had trained. The difference between my father's outcome and my current bloods is not a new drug. It is not a new procedure. It is one combination from an ancient herb that has been in the mechanism literature for years while the guidelines were built around managing the downstream measurements that combination eventually makes unnecessary. If someone you love has Type 2 diabetes and their doctor is calling them managed, please share this with them. Managed is not improving. I know what improving looks like now. I have seen it in my own bloods and in eleven of my colleague's patients. It does not look like managed. It looks like the mechanism finally being addressed instead of downstream numbers being tracked while the mechanism continues grinding. Get the three-month supply. Follow the protocol. Give the mechanism the runway it requires. Your bloods will tell you everything you need to know by day ninety. Official Gevilo website only. Not Amazon. Not Holland & Barrett. Not any third-party seller. 👉 https://gevilo.com/pages/milk-thistle The system that trained me did not give me this when I needed it. It is reaching you now.